Previous 1 2 3 4 5
QIAGEN Acquires Genaco Biomedical Products, Inc.
QIAGEN N.V. , a leading provider of molecular diagnostics products and the world's premier supplier of solutions for preanalytical sample preparation, today announced that it acquired all outstanding shares of Genaco Biomedical Products, Inc. . (Mon, 30 Oct 2006 07:17:00 GMT)
QIAGEN Acquires Genaco Biomedical Products, Inc.
QIAGEN N.V. , a leading provider of molecular diagnostics products and the world's premier supplier of solutions for preanalytical sample preparation, today announced that it acquired all outstanding shares of Genaco Biomedical Products, Inc. . (Mon, 30 Oct 2006 07:46:00 GMT)
Bioscience firms in Germany, Ariz. link
A new Tempe-based bioscience company is linking up with a German company to distribute its technology in Europe, a move that could triple the local firm's annual revenue. (Mon, 30 Oct 2006 11:02:30 GMT)
Gene Has Key Role In Both Oxygen Sensing, Heat Shock Pathway
University of Oregon researchers have found an unexpected regulatory link between cellular responses to hypoxia and heat shock. Central to the discovery is a gene known as Hypoxia-Inducible Factor-1 that is critical for both normal and pathological changes, making it a potential target for both health promotion and cancer therapies. (Mon, 30 Oct 2006 11:05:11 GMT)
Key Molecular Signaling Switch Involved In Allergic Disease Identified
A research team has identified a key enzyme responsible for triggering a chain of events that results in allergic reaction, according to new study findings published online this week in Nature Immunology. (Mon, 30 Oct 2006 11:05:31 GMT)
Genetix gets board recommendation after upping offer for Applied Imaging
The cell biology, proteomics and genomics health technology group, said it raised its offer after Applied Imaging announced that it had received a superior offer from a third party and was therefore terminating its prior recommendation of the deal with Genetix. (Mon, 30 Oct 2006 11:09:37 GMT)
(AFX UK Focus) 2006-10-30 11:09 GMT: Genetix gets board recommendation after upping offer for Applied Imaging
LONDON (AFX) - Genetix Group PLC said it has received a board recommendation after it once again raised its offer for Applied Imaging Corporation, this time to 22.5 mln usd from the previous 21.3 mln. (Mon, 30 Oct 2006 11:22:44 GMT)
Alzheimer's breakthrough could mean earlier diagnosis
Scientists are a step closer to finding a blood test for Alzheimer's disease to diagnose people before they show symptoms. Researchers have discovered that levels of two types of protein found in the blood can indicate an increased risk of having the disease (Mon, 30 Oct 2006 11:23:05 GMT)
Nanogen Awarded Additional Patents for Diabetes, Alzheimer's Disease Biomarkers
Nanogen, Inc. , developer of advanced diagnostic products, announced today that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimer's disease biomarkers. (Mon, 30 Oct 2006 13:00:00 GMT)
Nanogen to Host Third Quarter Conference Call and Webcast on November 1, 2006
Nanogen, Inc. , developer of advanced diagnostic products, will host a conference call on Wednesday, November 1, 2006 at 4:30 p.m. Eastern to discuss 2006 third quarter financial results. (Mon, 30 Oct 2006 13:00:00 GMT)
Bacterial 'Switch Gene' Regulates Oceans' Sulfur Emissions Into The Air
A team of researchers, led by marine microbial ecologist Mary Ann Moran at the University of Georgia, has discovered a bacterial "switch gene" in two groups of plankton. This gene helps determine whether certain marine bacterioplankton convert a sulfur compound to one that rises into the atmosphere and affects the earth's temperature or remains climatically inactive in the seas. (Mon, 30 Oct 2006 13:05:40 GMT)
Remember This: Receptors Govern How Brain Cells Communicate
An hour from now, will you remember reading this? It all depends on proteins in your brain called NMDA receptors, which allow your neurons to communicate with each other. University of Pittsburgh researchers have discovered how different types of NMDA receptors perform varied functions. Their findings are published in the current issue of the Journal of Neuroscience. (Mon, 30 Oct 2006 13:06:12 GMT)
Researchers Discover Key Mechanism By Which Lethal Viruses Ebola And Marburg Cause Disease
Researchers in the Greene Infectious Disease Laboratory at Columbia University's Mailman School of Public Health, the Centers for Disease Control and Prevention, and the Caribbean Primate Research Center have discovered a key mechanism by which the Filoviruses, Ebola and Marburg, cause disease. (Mon, 30 Oct 2006 13:07:48 GMT)
Women On Hormone Therapy Regain Emotion Response
Older women on hormone therapy are more sensitive to negative events, confirming speculation that age-related estrogen loss affects the brain's ability to process emotion, an Oregon Health & Science University study shows. Researchers found that hormone therapy appears to reverse the age-related loss of arousal to negative emotional events experienced by the elderly. It also points to specific (Mon, 30 Oct 2006 13:09:10 GMT)
Hope for Alzheimer's blood test
UK scientists are developing a blood test which may pick up signs of Alzheimer's disease earlier. (Mon, 30 Oct 2006 13:52:40 GMT)
Nanogen Awarded Additional Patents for Diabetes, Alzheimer's Disease Biomarkers
SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- Nanogen, Inc. , developer of advanced diagnostic products, announced today that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimer's disease biomarkers. (Mon, 30 Oct 2006 15:30:47 GMT)
NASA Spaceline 19 October 2006 Current Space Life Science Awareness
Heinemeier KM, Olesen JL, Schjerling P, Haddad F, Langberg H, Baldwin KM, Kjaer M. Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and -tendon: Differential effects of specific contraction types. (Mon, 30 Oct 2006 16:35:03 GMT)
NASA Spaceline 19 October 2006 Current Space Life Science Awareness
Quelle: Space Wire Top Stories (Mon, 30 Oct 2006 16:38:44 GMT)
UVic-Genome British Columbia Proteomics Centre Attracts Leading Chemist
Vancouver, BC, October 30, 2006--(T-Net)--Dr. Christoph Borchers, formerly director of the UNC-Duke Proteomics Facility at the University of North Carolina at Chapel Hill and a pioneer in the burgeoning field of proteomics research, is the new director of the UVic centre. (Mon, 30 Oct 2006 17:15:40 GMT)
Detecting rare microRNAs with gold nanoparticles
Over the past three years, numerous studies have shown that short pieces of single-stranded RNA, known as microRNAs, play a central role in the development of at least some cancers. (Mon, 30 Oct 2006 18:09:55 GMT)
Clinical Data's Cogenics and VWR International Announce Strategic Alliance
Clinical Data, ( Nachrichten ) Inc. (NASDAQ: CLDA) and VWR International, Inc. today announced a strategic alliance to utilize VWR ' s comprehensive sales network to generate qualified leads for DNA sequencing services for Clinical Data ' s Cogenics Division, including Lark and Genome Express, in Europe ' s industrial and academic bioresearch markets. (Mon, 30 Oct 2006 19:50:41 GMT)
Bio-IT Briefs
October 30, 2006 | ClinPhone , a global clinical technology solutions, has acquired DataLabs , a premier electronic data capture (EDC) vendor. This acquisition enables ClinPhone to offer a comprehensive suite of clinical trial management and data capture systems. (Mon, 30 Oct 2006 20:04:01 GMT)
Sigma-Aldrich Launches First Commercially Available Proteomics Standard
Sigma-Aldrich , a $1.7 billion Life Science and High Technology company, announced the release of the Universal Proteomics Standard during the HUPO Protein Test Sample Standards/NIST Workshop, an educational session prior to the HUPO 5th Annual World Congress. (Mon, 30 Oct 2006 21:00:00 GMT)
The power behind insect flight: Researchers reveal key kinetic component
Troy, N.Y. – Researchers from Rensselaer Polytechnic Institute and the University of Vermont have discovered a key molecular mechanism that allows tiny flies and other "no-see-ums" to whirl their wings at a dizzying rate of up to 1,000 times per second. (Mon, 30 Oct 2006 22:14:45 GMT)
The Power Behind Insect Flight: Researchers Reveal Key Kinetic Component
Researchers from Rensselaer Polytechnic Institute and the University of Vermont have discovered a key molecular mechanism that allows tiny flies and other "no-see-ums" to whirl their wings at a dizzying rate of up to 1,000 times per second. The findings are being reported in the Oct. 30-Nov. 3 online early edition of the Proceedings of the National Academy of Sciences (PNAS). (Mon, 30 Oct 2006 22:24:41 GMT)
Scientists discover two-component lantibiotic with therapeutic potential
CHAMPAIGN, Ill. -- The discovery and preparation of a naturally occurring antibiotic could open the door to new therapeutic drugs for treating nasty infections. (Mon, 30 Oct 2006 22:25:34 GMT)
Phoenix rising: Scientists resuscitate a 5 million-year-old retrovirus
VILLEJUIF, France (Tues., Oct. 31, 2006) -- A team of scientists has reconstructed the DNA sequence of a 5-million-year-old retrovirus and shown that it is able to produce infectious particles. (Mon, 30 Oct 2006 22:25:54 GMT)
Method and system for anonymous communication of information about a home
A system for establishing anonymous communications includes a plurality of party terminals, a plurality of requester terminals, and a central controller. The system receives and stores party data about respective (Mon, 30 Oct 2006 23:10:15 GMT)
Three new lung tumor subtypes identified in DNA profiling study
CHAPEL HILL -- A new study has identified three subtypes of non-small-cell lung cancer tumors, a finding that may provide valuable clinical information about patient survival in early- or late-stage disease, how likely the cancer is to spread and whether the tumor will prove resistant to chemotherapy. (Mon, 30 Oct 2006 23:10:22 GMT)
Update -- Merck's $1 Billion Bet
The drugmaker buys a stake in a tiny biotech based on a Nobel Prize-winning medical discovery. (Tue, 31 Oct 2006 00:23:51 GMT)
Sigma-Aldrich Launches First Commercially Available Proteomics Standard
ST. LOUIS, Oct. 30 /PRNewswire-FirstCall/ -- S (Tue, 31 Oct 2006 02:35:21 GMT)
Looking for ways to keep cybersnoops out
The International Islamic University of Malaysia (IIUM) and research body Mimos Bhd are working together to develop ways to protect national secrets and other sensitive information from digital snoops on the Internet. (Tue, 31 Oct 2006 03:57:27 GMT)
Valley tissue banks draw interest from researchers
Tissue banks in the Valley could draw more researchers, companies and high-wage jobs to the Valley and Arizona. (Tue, 31 Oct 2006 04:23:26 GMT)
Two National Diabetes-Related Initiatives Coordinated By MCG Bioinformatics Expert
A national effort to develop animal models to study the devastating complications of diabetes is being coordinated by a Medical College of Georgia bioinformatics expert.Dr. Richard A. [click link for full article] (Tue, 31 Oct 2006 06:11:01 GMT)
Study suggests Alzheimer's test could be near
British researchers say discovery of proteins connected with the disease could spur earlier treatment. (Tue, 31 Oct 2006 11:04:23 GMT)
Scientists Discover Two-component Lantibiotic With Therapeutic Potential
The discovery and preparation of a naturally occurring antibiotic could open the door to new therapeutic drugs for treating nasty infections. (Tue, 31 Oct 2006 11:05:31 GMT)
Ghost Protein Leaves Fresh Tracks In The Cell
Spectrin and ankyrin, two essential proteins, shape and fortify cell membranes. New findings on variations in spectrin's ability to bind to membranes have implications for new biomedical molecular targets to treat certain diseases. (Tue, 31 Oct 2006 11:06:25 GMT)
Three New Lung Tumor Subtypes Identified In DNA Profiling Study
A new study has identified three subtypes of non-small-cell lung cancer tumors, a finding that may provide valuable clinical information about patient survival in early- or late-stage disease, how likely the cancer is to spread and whether the tumor will prove resistant to chemotherapy. (Tue, 31 Oct 2006 11:06:33 GMT)
Analysis Of Breast-cancer Gene Role Offers Promising Target
Researchers at UT Southwestern Medical Center have for the first time described how multiple copies of a gene are responsible for metastases in early-stage breast cancer and poor prognosis for patients. (Tue, 31 Oct 2006 11:06:44 GMT)
Merck to acquire S.F.-based Sirna
Merck will acquire San Francisco biotechnology company Sirna Therapeutics for $1.1 billion in cash, the pharmaceutical giant said Monday. (Tue, 31 Oct 2006 11:15:37 GMT)
AnaSpec Introduces “Search by Research Topic” Functionality AnaSpec, Inc. Posted on: 30 Oct 06
In an effort to optimize the search processes of its customers, AnaSpec, a leading provider of integrated proteomics solutions, now offers a new web search function for browsing its products according to research topic. (Tue, 31 Oct 2006 11:36:15 GMT)
DNAPrint Genomics Partner, Biofrontera A.G., Commences Trading on German Stock Exchanges
DNAPrint Genomics, Inc. today announced that Biofrontera A.G., in which the Company now holds an approximate 10% stake, commenced trading of its common stock yesterday under the symbol B8F on the Börse Dusseldorf, finishing the trading day at EUR 15.25, and commenced trading today on the Frankfurter Wertpapierbörse. (Tue, 31 Oct 2006 12:00:00 GMT)
Matritech Reports Third Quarter 2006 Financial Results
NEWTON, Mass.----Matritech , a leading developer of protein-based diagnostic products for the early detection of cancer, today reported financial results for the third quarter ended September 30, 2006. (Tue, 31 Oct 2006 12:00:00 GMT)
Applied Biosystems Announces Collaboration with Eagle Research and Development
FOSTER CITY, Calif.----Applied Biosystems Group , an Applera Corporation business, today announced that it has signed an agreement with Eagle Research and Development, LLC to collaborate on further developing a single molecule detection device invented by Eagle. (Tue, 31 Oct 2006 12:00:00 GMT)
Are you susceptible to Alzheimer's? Take a blood test
Experts at Kings College, London have revealed that a new blood test may actually help doctors predict the onset of Alzheimer's. (Tue, 31 Oct 2006 12:08:27 GMT)
Avecia and Illumigen Announce Development and Manufacturing Agreement
Avecia and Illumigen Biosciences Inc., a genomics-driven drug discovery and development company, have entered into an agreement for the process development and manufacture of Illumigen's lead development product, IB657, for the treatment of Hepatitis C and other RNA viruses. (Tue, 31 Oct 2006 13:00:00 GMT)
Heiner Dreismann, Former Roche Executive, Joins Nanogen Board of Directors
SAN DIEGO, Oct. 31 /PRNewswire-FirstCall/ -- Nanogen, ( Nachrichten ) Inc. , developer of advanced diagnostic products, announced today that Heiner Dreismann, Ph.D. has been named to its Board of Directors. (Tue, 31 Oct 2006 13:21:14 GMT)
Harvard Medical School Researchers to Build Next Generation Discovery and Diagnostics Methods with Lumera's
Lumera Corporation ( Nachrichten ) (Nasdaq:LMRA), an emerging leader in the field of nanotechnology, announced that Harvard Medical School researchers are now building next generation discovery and diagnostics methods with Lumera ' s ProteomicProcessor â„¢ Biosensor. (Tue, 31 Oct 2006 14:08:17 GMT)
2ND UPDATE: Sirna Therapeutics' Shares Rocket On Merck Buyout Pact
BOSTON (Dow Jones) -- Sirna Therapeutics Inc. shares nearly doubled early Tuesday, playing off Merck & Co.'s definitive agreement to buy the research group for $1.1 billion in cash. (Tue, 31 Oct 2006 15:01:02 GMT)
Merck's $1 Billion Bet
The drugmaker buys a stake in a tiny biotech based on a Nobel Prize-winning medical discovery. (Tue, 31 Oct 2006 16:11:46 GMT)
DNAPrint Genomics Partner, Biofrontera A.G., Commences Trading on German Stock Exchanges
DNAPrint Genomics, Inc. (OTCBB: DNAG) todayannounced that Biofrontera A.G., in which the Company now holds anapproximate 10% stake, commenced trading of its common stock yesterdayunder the symbol B8F on the Börse Dusseldorf (Dusseldorf Stock Exchange),finishing the trading day at EUR 15.25 (approximately $19.40 US), andcommenced trading today on the Frankfurter Wertpapierbörse (Frankfurt (Tue, 31 Oct 2006 17:10:18 GMT)
Avecia and Illumigen Announce Development and Manufacturing Agreement
TEES VALLEY, England and SEATTLE, Washington, O (Tue, 31 Oct 2006 17:12:56 GMT)
DNAPrint Genomics Partner, Biofrontera A.G., Commences Trading on German Stock Exchanges
DNAPrint Genomics, Inc. (OTCBB: DNAG) today ann (Tue, 31 Oct 2006 17:16:18 GMT)
Bio-IT Briefs
October 31, 2006 | Liquid Computing Corp . announced the general availability of LiquidIQ, its interconnect driven server. (Tue, 31 Oct 2006 17:48:03 GMT)
NIH Licenses BIOBASE's TRANSFAC And PROTEOME Databases
BIOBASE, a provider of expert-maintained biological databases and analysis software for the life science industry, announced today the signing of a licensing agreement with the National Institutes of Health (NIH) for the PROTEOME databases (Tue, 31 Oct 2006 19:09:48 GMT)
Scientists discover two-component lantibiotic with therapeutic potential
The discovery and preparation of a naturally occurring antibiotic could open the door to new therapeutic drugs for treating nasty infections. (Tue, 31 Oct 2006 19:50:17 GMT)
Lumera, Harvard Proteomics Institute Will Use NAPPA Tech to Probe 200 Kinase Proteins
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb? Register quickly here for your free subscription. (Tue, 31 Oct 2006 20:01:34 GMT)
Jefferson scientists show gene reverts cancer genes to normal, predicts breast cancer prognosis
(PHILADELPHIA) Scientists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have shown that the activity of a gene that commandeers other cancer-causing genes, returning them to normal, can predict the prognosis of an individual with breast cancer. (Tue, 31 Oct 2006 21:40:24 GMT)
Lumera stock soars after Harvard announcement
Shares in Lumera Corp. soared more than 37 percent Tuesday after the company announced that Harvard Medical School researchers are using the company's nanotechnology instruments. (Tue, 31 Oct 2006 22:19:30 GMT)
Two of the World's Top Geneticists Are Coming to Miami
Two of the most acclaimed geneticists in the world, Dr. Margaret Pericak-Vance and Dr. Jeffery Vance of Duke University, are bringing their pioneering research into the genetics of a multitude of diseases to Miami. (Tue, 31 Oct 2006 23:15:17 GMT)
Previous 1 2 3 4 5
